Xiao-Dong Qian

419 citations
11 papers · 345 indexed · h-index 8
Topics
Cancer therapeutics and mechanisms (4 papers)Saffron Plant Research Studies (4 papers)Flavonoids in Medical Research (3 papers)

In The Last Decade

Xiao-Dong Qian

11 papers receiving 337 citations

Peers

Xiao-Dong Qian
Comparison fields: 5 of 73
  • Molecular Biology 194
  • Oncology 142
  • Organic Chemistry 84
  • Pharmacology 51
  • Neurology 36
Replace Oya Orun with:
Oya Orun Türkiye
Madeleine Blanc France
Víctor Mangas‐Sanjuan Spain
Barbora Lišková Czechia
Joseph Rager United States
Sravani Pulya India
Pedro de Sena Murteira Pinheiro Brazil
Mingde Xia United States
Amal Youssef Egypt
Shumaila Afrin India
Xiao-Dong Qian relative to Oya Orun Türkiye Oya Orun's profile →
Citations per field
00.5×
Oya Orun · 1×
Citations per year

Countries citing papers authored by Xiao-Dong Qian

Since Specialization
Citations

This map shows the geographic impact of Xiao-Dong Qian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao-Dong Qian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao-Dong Qian more than expected).

Fields of papers citing papers by Xiao-Dong Qian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiao-Dong Qian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao-Dong Qian. The network helps show where Xiao-Dong Qian may publish in the future.

Co-authorship network of co-authors of Xiao-Dong Qian

This figure shows the co-authorship network connecting the top 25 collaborators of Xiao-Dong Qian. A scholar is included among the top collaborators of Xiao-Dong Qian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiao-Dong Qian. Xiao-Dong Qian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1 2
2 31
3 45
4 21
5 2
6 17
7 2
8
Preclinical evaluation of LU 79553: a novel bis-naphthalimide with potent antitumor activity.
83
9
Bis-naphthalimides: a new class of antitumor agents.
52
10 39
11
Binding of an optically pure photoaffinity analogue of verapamil, LU-49888, to P-glycoprotein from multidrug-resistant human leukemic cell lines.
51

About Xiao-Dong Qian

Xiao-Dong Qian is a scholar working on Neurology, Pharmacology and Toxicology, having authored 11 papers that have together received 345 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (4 papers), Saffron Plant Research Studies (4 papers) and Flavonoids in Medical Research (3 papers). The work is most often cited by research in Toxicology (20 citations), Oncology (142 citations) and Neurology (36 citations). Xiao-Dong Qian has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include William T. Beck, Peter F. Bousquet, Donna Conlon, Yilu Ye, Qi Zhang, Richard A. Miller, Jonathan S. George, Kathleen Fitzgerald, Miguel F. Braña and J. A. Houghton. Their work appears in journals such as European Journal of Pharmacology, Biomedicine & Pharmacotherapy and Analytical Methods.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026